CONCORD HC GP(02453): The application for the license to configure large medical equipment for proton therapy devices has been approved by the National Health Commission.
Sinocare (02453) has issued an announcement, stating that the company has entered into an agreement with China on proton therapy equipment on April 29, 2024
CONCORD HC GP (02453) announced that the company submitted an application for a license to operate proton therapy equipment to the National Health Commission of the People's Republic of China (NHC) on April 29, 2024.
The board of directors is pleased to announce that the NHC approved the company's license application on September 13, 2024.
The operation of proton therapy services will begin as soon as several deployments are completed. The company will provide more updated information on the significant progress of its planned proton therapy services in due course.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
